A-Alpha Bio is building a high-resolution model of biology by measuring protein interactions.

A-Alpha leverages its platform technology AlphaSeq to generate high-quality protein interaction data at scale, enabling the discovery of better drugs faster.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • David Younger
  • Randolph Lopez

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • A-Alpha Bio has been selected as a finalist for the annual @geekwire Awards Health Innovation of the Year! It's a f… https://t.co/FAqXQjQqJq@AAlphaBio - 02:16 AM Mar 29th
  • We are very excited to announce our collaboration with @Livermore_Lab to accelerate antibody discovery for emergin… https://t.co/C5ldVWhIbY@AAlphaBio - 02:40 PM Mar 1st
  • As we prepare for a virtual company-wide retreat tomorrow, we can't help but reminisce on previous in-person team e… https://t.co/absa4jJjAW@AAlphaBio - 10:12 PM Jan 27th